Anti-inflammatory, antioxidant, and immunomodulatory effects of Berberis vulgaris and its constituent berberine, experimental and clinical, a review.

Publisher: Wiley Country of Publication: England NLM ID: 8904486 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1573 (Electronic) Linking ISSN: 0951418X NLM ISO Abbreviation: Phytother Res Subsets: MEDLINE

Publication: : Chichester : Wiley
Original Publication: London : Heyden & Son, c1987-

Berberine*/pharmacology ; Berberine*/therapeutic use ; Berberis*; Antioxidants/pharmacology ; Antioxidants/metabolism ; Cytokines ; Anti-Inflammatory Agents/pharmacology

Berberis vulgaris (B. vulgaris or barberry) is a medicinal plant that has been used for various purposes in traditional medicine. Berberine is one of the main alkaloids isolated from B. vulgaris and other plants. Both B. vulgaris and berberine have shown anti-inflammatory, antioxidant, and immunomodulatory effects in different experimental models and clinical trials. This review aims to summarize the current evidence on the mechanisms and applications of B. vulgaris and berberine in modulating inflammation, oxidative stress, and immune responses. The literature search was performed using PubMed, Scopus, and Google Scholar databases until August 2023. The results indicated that B. vulgaris and berberine could inhibit the production of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), interleukin 6 (IL-6), and interleukin-17 (IL-17), and enhance the expression of anti-inflammatory cytokines, such as interleukin 10 (IL-10) and transforming growth factor-β (TGF-β), in various cell types and tissues. B. vulgaris and berberine can also scavenge free radicals, increase antioxidant enzymes, such as superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), and reduce lipid peroxidation and DNA damage. B. vulgaris and berberine have been reported to exert beneficial effects in several inflammatory, oxidative, and immune-related diseases, such as diabetes, obesity, cardiovascular diseases, neurodegenerative diseases, autoimmune diseases, allergic diseases, and infections. However, more studies are needed to elucidate the optimal doses, safety profiles, and potential interactions of B. vulgaris and berberine with other drugs or natural compounds.
(© 2024 John Wiley & Sons Ltd.)

Abdulredha, A., Abosaooda, M., Al‐Amran, F., & Hadi, N. R. (2021). Berberine protests the heart from ischemic reperfusion injury via interference with oxidative and inflammatory pathways. Medical Archives, 75(3), 174–179.
Adefegha, S. A., Oboh, G., & Okeke, B. M. (2021). Comparative effects of berberine and piperine on the neuroprotective potential of neostigmine. Journal of Complementary and Integrative Medicine, 18(3), 491–497.
Adil, M., Kandhare, A. D., Dalvi, G., Ghosh, P., Venkata, S., Raygude, K. S., & Bodhankar, S. L. (2016). Ameliorative effect of berberine against gentamicin‐induced nephrotoxicity in rats via attenuation of oxidative stress, inflammation, apoptosis and mitochondrial dysfunction. Renal Failure, 38(6), 996–1006.
Alnuqaydan, A. M., Almutary, A. G., Azam, M., Manandhar, B., De Rubis, G., Madheswaran, T., Paudel, K. R., Hansbro, P. M., Chellappan, D. K., & Dua, K. (2022). Phytantriol‐based berberine‐loaded liquid crystalline nanoparticles attenuate inflammation and oxidative stress in lipopolysaccharide‐induced RAW264. 7 macrophages. Nanomaterials, 12(23), 4312.
Amidi, S., Mojab, F., Moghaddam, A. B., Tabib, K., & Kobarfard, F. (2012). A simple electrochemical method for the rapid estimation of antioxidant potentials of some selected medicinal plants. Iranian Journal of Pharmaceutical Research: IJPR, 11(1), 117–121.
An, Y.‐W., Jin, H.‐T., Yuan, B., Wang, J.‐C., Wang, C., & Liu, H.‐Q. (2021). Research progress of berberine mediated photodynamic therapy. Oncology Letters, 21(5), 1–10.
Aziz, M., Ghareeb, D., Eweda, S., Hussien, H., & Demellawy, M. E. J. B. (2015). Immunomodulatory effect of Berberis vulgaris extracts on murine splenocytes and enrichment of dendritic cells in vitro. Medical Biotechnology, 29(6), 1149–1155.
Bhutada, P., Mundhada, Y., Bansod, K., Tawari, S., Patil, S., Dixit, P., Umathe, S., & Mundhada, D. (2011). Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin‐induced diabetes. Behavioural Brain Research, 220(1), 30–41.
Chatuphonprasert, W., Lao‐Ong, T., & Jarukamjorn, K. (2014). Improvement of superoxide dismutase and catalase in streptozotocin–nicotinamide‐induced type 2‐diabetes in mice by berberine and glibenclamide. Pharmaceutical Biology, 52(4), 419–427.
Chen, F., Yang, Z., Liu, Y., Li, L., Liang, W., Wang, X., Zhou, W. B., Yang, Y. H., & Hu, R.‐M. (2008). Berberine inhibits the expression of TNFα, MCP‐1, and IL‐6 in AcLDL‐stimulated macrophages through PPARγ pathway. Endocrine, 33, 331–337.
Chen, X., Zhang, Y., Zhu, Z., Liu, H., Guo, H., Xiong, C., Xie, K., Zhang, X., & Su, S. (2016). Protective effect of berberine on doxorubicin‐induced acute hepatorenal toxicity in rats. Molecular Medicine Reports, 13(5), 3953–3960.
Cheng, F., Wang, Y., Li, J., Su, C., Wu, F., Xia, W.‐H., Yang, Z., Yu, B., Qiu, Y., & Tao, J. (2013). Berberine improves endothelial function by reducing endothelial microparticles‐mediated oxidative stress in humans. International Journal of Cardiology, 167(3), 936–942.
Chu, X., Zhou, Y., Zhang, B., Xue, B., & Zhao, Y. (2017). Berberine attenuates cerebral ischemia‐reperfusion injury via activating PI3K‐Akt signaling in a rat model of type 2 diabetes. International Journal of Clinical and Experimental Medicine, 10(12), 16196–16202.
Chueh, W.‐H., & Lin, J.‐Y. (2012). Protective effect of isoquinoline alkaloid berberine on spontaneous inflammation in the spleen, liver and kidney of non‐obese diabetic mice through downregulating gene expression ratios of pro‐/anti‐inflammatory and Th1/Th2 cytokines. Food Chemistry, 131(4), 1263–1271.
Cui, G., Qin, X., Zhang, Y., Gong, Z., Ge, B., & Zang, Y. Q. (2009). Berberine differentially modulates the activities of ERK, p38 MAPK, and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice. The Journal of Biological Chemistry, 284(41), 28420–28429.
Cui, G., Wang, H., Yang, C., Zhou, X., Wang, J., Wang, T., & Ma, T. (2022). Berberine prevents lethal EV71 neurological infection in newborn mice. Frontiers in Pharmacology, 13, 1027566.
Cui, H., Cai, Y., Wang, L., Jia, B., Li, J., Zhao, S., Chu, X., Lin, J., Bian, Y. & Zhuang, P. (2018). Berberine regulates Treg/Th17 balance to treat ulcerative colitis through modulating the gut microbiota in the colon. Frontiers in Pharmacology, 9, 571.
Deng, Y., Tang, K., Chen, R., Nie, H., Liang, S., Zhang, J., Zhang, Y., & Yang, Q. (2019). Berberine attenuates hepatic oxidative stress in rats with non‐alcoholic fatty liver disease via the Nrf2/ARE signalling pathway. Experimental and Therapeutic Medicine, 17(3), 2091–2098.
Dinesh, P., & Rasool, M. J. (2019). Berberine mitigates IL‐21/IL‐21R mediated autophagic influx in fibroblast‐like synoviocytes and regulates Th17/Treg imbalance in rheumatoid arthritis. Apoptosis, 24(7–8), 644–661.
Domadia, P. N., Bhunia, A., Sivaraman, J., Swarup, S., & Dasgupta, D. (2008). Berberine targets assembly of Escherichia coli cell division protein FtsZ. Biochemistry, 47(10), 3225–3234.
Domitrović, R., Jakovac, H., Marchesi, V. V., & Blažeković, B. (2013). Resolution of liver fibrosis by isoquinoline alkaloid berberine in CCl4‐intoxicated mice is mediated by suppression of oxidative stress and upregulation of MMP‐2 expression. Journal of Medicinal Food, 16(6), 518–528.
El‐Zahar, K. M., Al‐Jamaan, M. E., Al‐Mutairi, F. R., Al‐Hudiab, A. M., Al‐Einzi, M. S., & Mohamed, A. A.‐Z. (2022). Antioxidant, antibacterial, and antifungal activities of the ethanolic extract obtained from Berberis vulgaris roots and leaves. Molecules, 27(18), 6114.
Emamat, H., Zahedmehr, A., Asadian, S., Nasrollahzadeh, J. J. (2022). The effect of barberry (Berberis integerrima) on lipid profile and systemic inflammation in subjects with cardiovascular risk factors: a randomized‐controlled trial. BMC Complementary Medicine and Therapies, 22(1), 59.
Emamat, H., Zahedmehr, A., Asadian, S., Tangestani, H., & Nasrollahzadeh, J. (2020). Effect of barberry (Berberis vulgaris) consumption on blood pressure, plasma lipids, and inflammation in patients with hypertension and other cardiovascular risk factors: Study protocol for a randomized clinical trial. Trials, 21(1), 1–9.
Fouad, G. I., & Ahmed, K. A. (2021). The protective impact of berberine against doxorubicin‐induced nephrotoxicity in rats. Tissue and Cell, 73, 101612.
Fukuda, K., Hibiya, Y., Mutoh, M., Koshiji, M., Akao, S., & Fujiwara, H. J. (1999). Inhibition by berberine of cyclooxygenase‐2 transcriptional activity in human colon cancer cells. Journal of Ethnopharmacology, 66(2), 227–233.
Gautam, S. C., Gao, X., & Dulchavsky, S. (2007). Immunomodulation by curcumin. In The molecular targets and therapeutic uses of curcumin in health and disease (pp. 321–341). Springer.
Gholamnezhad, Z., Keyhanmanesh, R., & Boskabady, M. H. (2015). Anti‐inflammatory, antioxidant, and immunomodulatory aspects of Nigella sativa for its preventive and bronchodilatory effects on obstructive respiratory diseases: A review of basic and clinical evidence. Journal of Functional Foods, 17, 910–927.
Hajipour, S., Farbood, Y., Dianat, M., Nesari, A., & Sarkaki, A. (2023). Effect of berberine against cognitive deficits in rat model of thioacetamide‐induced liver cirrhosis and hepatic encephalopathy (behavioral, biochemical, molecular and histological evaluations). Brain Sciences, 13(6), 944.
Han, C. Y., Sun, T. T., Xv, G. P., Wang, S. S., Gu, J. G., & Liu, C. Y. (2019). Berberine ameliorates CCl4‐induced liver injury in rats through regulation of the Nrf2‐Keap1‐ARE and p53 signaling pathways. Molecular Medicine Reports, 20(4), 3095–3102.
Hanachi, P., Kua, S., Asmah, R., Motalleb, G., & Fauziah, O. (2006). Cytotoxic effect of Berberis vulgaris fruit extract on the proliferation of human liver cancer cell line (HepG2) and its antioxidant properties. International Journal of Cancer Research, 2(1), 1–9.
Hasanein, P., Ghafari‐Vahed, M., & Khodadadi, I. (2017). Effects of isoquinoline alkaloid berberine on lipid peroxidation, antioxidant defense system, and liver damage induced by lead acetate in rats. Redox Report, 22(1), 42–50.
Hasani‐Ranjbar, S., Larijani, B., & Abdollahi, M. (2009). A systematic review of the potential herbal sources of future drugs effective in oxidant‐related diseases. Inflammation & Allergy‐Drug Targets (Formerly Current Drug Targets‐Inflammation & Allergy), 8(1), 2–10.
Homayoonfal, M., Mousavi, S. M., Kiani, H., Askari, G., Desobry, S., & Arab‐Tehrany, E. (2021). Encapsulation of berberis vulgaris anthocyanins into nanoliposome composed of rapeseed lecithin: A comprehensive study on physicochemical characteristics and biocompatibility. Food, 10(3), 492.
Hoshyar, R., Mahboob, Z., & Zarban, A. (2016). The antioxidant and chemical properties of Berberis vulgaris and its cytotoxic effect on human breast carcinoma cells. Cytotechnology, 68, 1207–1213.
Hostalkova, A., Marikova, J., Opletal, L., Korabecny, J., Hulcova, D., Kunes, J., Novakova, L., Perez, D., Jun, D., Kucera, T., Andrisano, V., Siatka, T., & Cahlikova, L. (2019). Isoquinoline alkaloids from Berberis vulgaris as potential lead compounds for the treatment of Alzheimer's disease. Journal of Natural Products, 82(2), 239–248.
Huang, C. G., Chu, Z. L., Wei, S. J., Jiang, H., & Jiao, B. H. (2002). Effect of berberine on arachidonic acid metabolism in rabbit platelets and endothelial cells. Thrombosis Research, 106(4–5), 223–227.
Imanshahidi, M., & Hosseinzadeh, H. (2008). Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytotherapy Research, 22(8), 999–1012.
Imenshahidi, M., & Hosseinzadeh, H. (2016). Berberis vulgaris and berberine: an update review. Phytotherapy Research, 30(11), 1745–1764.
Imenshahidi, M., & Hosseinzadeh, H. (2019). Berberine and barberry (Berberis vulgaris): A clinical review. Phytotherapy Research, 33(3), 504–523.
Ivanovska, N., & Philipov, S. J. (1996). Study on the anti‐inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. International Journal of Immunopharmacology, 18(10), 553–561.
Jeong, H. W., Hsu, K. C., Lee, J.‐W., Ham, M., Huh, J. Y., & Shin, H. J. (2009). Berberine suppresses proinflammatory responses through AMPK activation in macrophages. American Journal of Physiology. Endocrinology and Metabolism, 296(4), E955–E964.
Jia, L., Xue, K., Liu, J., Habotta, O. A., Hu, L., & Moneim, A. E. A. (2020). Anticolitic effect of berberine in rat experimental model: Impact of PGE2/p38 MAPK pathways. Mediators of Inflammation, 2020, 1–12.
Jia, X., Shao, W., & Tian, S. (2022). Berberine alleviates myocardial ischemia–reperfusion injury by inhibiting inflammatory response and oxidative stress: The key function of miR‐26b‐5p‐mediated PTGS2/MAPK signal transduction. Pharmaceutical Biology, 60(1), 652–663.
Ju, J., Li, J., Lin, Q., & Xu, H. (2018). Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta‐analysis of randomized clinical trials. Phytomedicine, 50, 25–34.
Kalmarzi, R. N., Naleini, S. N., Ashtary‐Larky, D., Peluso, I., Jouybari, L., Rafi, A., Ghorat, F., Heidari, N., Sharifian, F., Mardaneh, J., Aiello, P., Helbi, S., & Kooti, W. (2019). Anti‐inflammatory and immunomodulatory effects of barberry (Berberis vulgaris) and its main compounds. Oxidative Medicine and Cellular Longevity, 2019, 1–10.
Kazaz, I. O., Mentese, A., Demir, S., Kerimoglu, G., Colak, F., Bodur, A., Kutlu, O., Alver, A., & Turedi, S. (2020). Berberine inhibits the ischemia‐reperfusion induced testicular injury through decreasing oxidative stress. The American Journal of Emergency Medicine, 38(1), 33–37.
Khazdair, M., Alavinezhad, A., & Boskabady, M. (2018). Carvacrol ameliorates haematological parameters, oxidant/antioxidant biomarkers and pulmonary function tests in patients with Sulphur mustard‐induced lung disorders: A randomized double‐blind clinical trial. Journal of Clinical Pharmacy and Therapeutics, 43(5), 664–674.
Khazdair, M. R., Ghorani, V., Alavinezhad, A., & Boskabady, M. H. (2018). Pharmacological effects of Zataria multiflora Boiss L. and its constituents focus on their anti‐inflammatory, antioxidant, and immunomodulatory effects. Fundamental & Clinical Pharmacology, 32(1), 26–50.
Kim, H. J. (2015). Berberine ameliorates allodynia induced by chronic constriction injury of the sciatic nerve in rats. Journal of Medicinal Food, 18(8), 909–915.
Končić, M. Z., Kremer, D., Karlović, K., & Kosalec, I. (2010). Evaluation of antioxidant activities and phenolic content of Berberis vulgaris L. and Berberis croatica Horvat. Food and Chemical Toxicology, 48(8–9), 2176–2180.
Kooti, W., Farokhipour, M., Asadzadeh, Z., Ashtary‐Larky, D., & Asadi‐Samani, M. (2016). The role of medicinal plants in the treatment of diabetes: A systematic review. Electronic Physician, 8(1), 1832–1842.
Kulkarni, S., & Dhir, A. (2010). Berberine: A plant alkaloid with therapeutic potential for central nervous system disorders. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 24(3), 317–324.
Lan, J., Zhao, Y., Dong, F., Yan, Z., Zheng, W., Fan, J., & Sun, G. (2015). Meta‐analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. Journal of Ethnopharmacology, 161, 69–81.
Lao‐ong, T., Chatuphonprasert, W., Nemoto, N., & Jarukamjorn, K. (2012). Alteration of hepatic glutathione peroxidase and superoxide dismutase expression in streptozotocin‐induced diabetic mice by berberine. Pharmaceutical Biology, 50(8), 1007–1012.
Lazavi, F., Mirmiran, P., Sohrab, G., Nikpayam, O., Angoorani, P., & Hedayati, M. (2018). The barberry juice effects on metabolic factors and oxidative stress in patients with type 2 diabetes: A randomized clinical trial. Complementary Therapies in Clinical Practice, 31, 170–174.
Li, C., Xi, Y., Li, S., Zhao, Q., Cheng, W., Wang, Z., Zhong, J., Niu X, & Chen, G. J. (2015). Berberine ameliorates TNBS induced colitis by inhibiting inflammatory responses and Th1/Th17 differentiation. Molecular Immunology, 67(2), 444–454.
Liu, H., You, L., Wu, J., Zhao, M., Guo, R., Zhang, H., Su, R., Mao, Q., Deng, D., & Hao, Y. (2020). Berberine suppresses influenza virus‐triggered NLRP3 inflammasome activation in macrophages by inducing mitophagy and decreasing mitochondrial ROS. Journal of Leucocyte Biology, 108(1), 253–266.
Liu, J., Liu, P., Xu, T., Chen, Z., Kong, H., Chu, W., Wang, Y., & Liu, Y. (2020). Berberine induces autophagic cell death in acute lymphoblastic leukemia by inactivating AKT/mTORC1 signaling. Drug Design, Development and Therapy, 12(14), 1813–1823.
Liu, W.‐h., Hei, Z.‐q., Nie, H., Tang, F.‐t., Huang, H.‐q., Li, X.‐j., Deng, Y. H., Chen, S. R., Guo, F. F., Huang, W. G., Chen, F. Y., & Liu, P. Q. (2008). Berberine ameliorates renal injury in streptozotocin‐induced diabetic rats by suppression of both oxidative stress and aldose reductase. Chinese Medical Journal, 121(08), 706–712.
Liu, X., Zhang, X., Ye, L., & Yuan, H. J. B. (2016). Protective mechanisms of berberine against experimental autoimmune myocarditis in a rat model. Biomedicine & Pharmacotherapy, 79, 222–230.
Liu, X., Zhou, J., Abid, M. D. N., Yan, H., Huang, H., Wan, L., Feng, Z., & Chen, J. (2014). Berberine attenuates axonal transport impairment and axonopathy induced by calyculin a in N2a cells. PLoS One, 9(4), e93974.
Lou, T., Zhang, Z., Xi, Z., Liu, K., Li, L., Liu, B., & Huang, F. (2011). Berberine inhibits inflammatory response and ameliorates insulin resistance in hepatocytes. Inflammation, 34, 659–667.
Lu, Y., Zhang, X., He, J., Dai, Z., Shi, P., Lu, Y., & Chang, F. (2022). The effects of berberine on inflammatory markers in Chinese patients with metabolic syndrome and related disorders: A meta‐analysis of randomized controlled trials. Inflammopharmacology, 30(3), 1063–1077.
Marinova, E. K., Nikolova, D. B., Popova, D. N., Gallacher, G. B., & Ivanovska, N. D. (2000). Suppression of experimental autoimmune tubulointerstitial nephritis in BALB/c mice by berberine. Immunopharmacology, 48(1), 9–16.
Minaiyan, M., Ghannadi, A., Mahzouni, P., & Jaffari‐Shirazi, E. J. (2011). Comparative study of Berberis vulgaris fruit extract and berberine chloride effects on acetic acid‐induced colitis in rats. Iranian Journal of Pharmaceutical Research, 10(1), 97.
Moghaddam, H. K., Baluchnejadmojarad, T., Roghani, M., Khaksari, M., Norouzi, P., Ahooie, M., & Mahboobi, F. (2014). Berberine ameliorate oxidative stress and astrogliosis in the hippocampus of STZ‐induced diabetic rats. Molecular Neurobiology, 49, 820–826.
Mohammadi, A., Sahebkar, A., Kermani, T., Zhilaee, M., Tavallaie, S., & Mobarhan, M. G. (2014). Barberry administration and pro‐oxidant–antioxidant balance in patients with metabolic syndrome. Iranian Red Crescent Medical Journal, 16(12), e16786.
Mohammadzadeh, N., Mehri, S., & Hosseinzadeh, H. J. (2017). Berberis vulgaris and its constituent berberine as antidotes and protective agents against natural or chemical toxicities. Iranian Journal of Basic Medical Sciences, 20(5), 538–551.
Mohd Nor, N. H., Othman, F., Mohd Tohit, E. R., Md Noor, S., Razali, R., Ahmad Hassali, H., & Hassan, H. (2019). In vitro Antiatherothrombotic effects of extracts from Berberis vulgaris L., Teucrium polium L., and Orthosiphon stamineus Benth. Evidence‐Based Complementary and Alternative Medicine, 2019, 1–10.
Mohebali, S., Nasri, S., Kamalinejhad, M., & Noori, A. S. (2011). Antinociceptive & anti‐inflammatory effects of Berberis vulgaris l. Root's hydro alcoholic extract and determination of it's possible antinociceptive mechanism in male mice. Archives of Advances in Biosciences, 2(4), 12–18.
Mohebbati, R., Anaeigoudari, A., & Khazdair, M. (2017). The effects of Curcuma longa and curcumin on reproductive systems. Endocrine Regulations, 51(4), 220–228.
Mokhtari‐Zaer, A., Norouzi, F., Askari, V. R., Khazdair, M. R., Roshan, N. M., Boskabady, M., Hosseini, M., & Boskabady, M. H. (2020). The protective effect of Nigella sativa extract on lung inflammation and oxidative stress induced by lipopolysaccharide in rats. Journal of Ethnopharmacology, 253, 112653.
Moon, P.‐D., Choi, I.‐H., & Kim, H.‐M. (2011). Berberine inhibits the production of thymic stromal lymphopoietin by the blockade of caspase‐1/NF‐κB pathway in mast cells. International Immunopharmacology, 11(11), 1954–1959.
Naghdi, F., Saadat, S., Gholamnezhad, Z., Rakhshandeh, H., & Boskabady, M. (2022). Muscarinic receptors blockade and nitric oxide production contribute in the relaxant effect of Berberis vulgaris extract on rat tracheal smooth muscle. Revue Française d'Allergologie, 62(4), 391–400.
Nam, K. N., Kim, J. H., Jung, H. J., Park, J. M., Moon, S. K., Kim, Y. S., Lee, E. H. J. N. R. R. (2010). Berberine inhibits inflammatory activation of rat brain microglia. Acta pharmacologica Sinica, 5(18), 1384–1390.
Özgen, M., Saraçoğlu, O., & Geçer, E. N. (2012). Antioxidant capacity and chemical properties of selected barberry (Berberis vulgaris L.) fruits. Horticulture, Environment, and Biotechnology, 53, 447–451.
Pan, L.‐r., Tang, Q., Fu, Q., Hu, B.‐r., Xiang, J.‐z., & Qian, J.‐q. (2005). Roles of nitric oxide in protective effect of berberine in ethanol‐induced gastric ulcer mice. Acta Pharmacologica Sinica, 26(11), 1334–1338.
Patel, P. (2021). A bird's eye view on a therapeutically ‘wonder molecule’: Berberine. Phytomedicine Plus, 1(3), 100070.
Saadat, S., Naghdi, F., Ghorani, V., Rakhshandeh, H., & Boskabady, M. H. (2019). Histamine (H1) receptors, cyclooxygenase pathway and nitric oxide formation involved in rat tracheal smooth muscle relaxant effect of berberine. Iranian Journal of Allergy, Asthma, and Immunology, 18(3), 320–331.
Sadeghnia, H. R., Kolangikhah, M., Asadpour, E., Forouzanfar, F., & Hosseinzadeh, H. (2017). Berberine protects against glutamate‐induced oxidative stress and apoptosis in PC12 and N2a cells. Iranian Journal of Basic Medical Sciences, 20(5), 594–603.
Sargin, İ. (2019). On fluorescent sensing of metal ions using water extracts of Salvia officinalis. Cumhuriyet Science Journal, 40(4), 830–837.
Schulz, V., Hänsel, R., Blumenthal, M., & Tyler, V. E. (2004). Agents that increase resistance to diseases. In Rational Phytotherapy: A Reference Guide for Physicians and Pharmacists (pp. 369–398). Springer.
Shao, J., Liu, S., Zheng, X., Chen, J., Li, L., & Zhu, Z. (2021). Berberine promotes peri‐implant osteogenesis in diabetic rats by ROS‐mediated IRS‐1 pathway. BioFactors, 47(1), 80–92.
Shekarabi, S. P. H., Mehrgan, M. S., Ramezani, F., Dawood, M. A., Van Doan, H., Moonmanee, T., Hamid, N. K. A., & Kari, Z. A. (2022). Effect of dietary barberry fruit (Berberis vulgaris) extract on immune function, antioxidant capacity, antibacterial activity, and stress‐related gene expression of Siberian sturgeon (Acipenser baerii). Aquaculture Reports, 23, 101041.
Sheng, M., Zhou, Y., Yu, W., Weng, Y., Xu, R., & Du, H. (2015). Protective effect of berberine pretreatment in hepatic ischemia/reperfusion injury of rat. Transplantation Proceedings, 47(2), 275–282.
Shidfar, F., Ebrahimi, S. S., Hosseini, S., Heydari, I., Shidfar, S., & Hajhassani, G. (2012). The effects of Berberis vulgaris fruit extract on serum lipoproteins, apoB, apoA‐I, homocysteine, glycemic control and total antioxidant capacity in type 2 diabetic patients. Iranian Journal of Pharmaceutical Research: IJPR, 11(2), 643–652.
Tang, L.‐Q., Wei, W., Chen, L.‐M., & Liu, S. (2006). Effects of berberine on diabetes induced by alloxan and a high‐fat/high‐cholesterol diet in rats. Journal of Ethnopharmacology, 108(1), 109–115.
Tian, L., Ri, H., Qi, J., & Fu, P. (2021). Berberine elevates mitochondrial membrane potential and decreases reactive oxygen species by inhibiting the rho/ROCK pathway in rats with diabetic encephalopathy. Molecular Pain, 17(1), 1–11.
Tilaoui, M., Jaafari, A., Ait Mouse, H., & Zyad, A. (2018). Studies on the dual cytotoxicity and antioxidant properties of Berberis vulgaris extracts and its main constituent berberine. Advances in Pharmacological and Pharmaceutical Sciences, 2018(1), 1–11.
Tillhon, M., Ortiz, L. M. G., Lombardi, P., & Scovassi, A. I. (2012). Berberine: New perspectives for old remedies. Biochemical Pharmacology, 84(10), 1260–1267.
Tong, J., Hou, X., Cui, D., Chen, W., Yao, H., Xiong, B., Cai, L., Zhang, H., & Jiang, L. (2022). A berberine hydrochloride‐carboxymethyl chitosan hydrogel protects against Staphylococcus aureus infection in a rat mastitis model. Carbohydrate Polymers, 278, 118910.
Visnagri, A., Kandhare, A. D., & Bodhankar, S. L. (2015). Renoprotective effect of berberine via intonation on apoptosis and mitochondrial‐dependent pathway in renal ischemia reperfusion‐induced mutilation. Renal Failure, 37(3), 482–493.
Wang, Y., Campbell, T., Perry, B., Beaurepaire, C., & Qin, L. (2011). Hypoglycemic and insulin‐sensitizing effects of berberine in high‐fat diet‐and streptozotocin‐induced diabetic rats. Metabolism, 60(2), 298–305.
Wang, Y., Liao, J., Luo, Y., Li, M., Su, X., Yu, B., Teng, J., Wang, H., & Lv, X. (2023). Berberine alleviates doxorubicin‐induced myocardial injury and fibrosis by eliminating oxidative stress and mitochondrial damage via promoting Nrf‐2 pathway activation. International Journal of Molecular Sciences, 24(4), 3257.
Wu, D., Wen, W., Qi, C.‐L., Zhao, R.‐X., Lü, J.‐H., Zhong, C.‐Y., & Chen, Y.‐Y. (2012). Ameliorative effect of berberine on renal damage in rats with diabetes induced by high‐fat diet and streptozotocin. Phytomedicine, 19(8–9), 712–718.
Wu, Y., Chuang, S., Hong, W., Lai, Y., Chang, G., & Pang, J. S. (2012). Berberine reduces leukocyte adhesion to LPS‐stimulated endothelial cells and VCAM‐1 expression both in vivo and in vitro. International Journal of Immunopathology and Pharmacology, 25(3), 741–750.
Xiang, X.‐Y., Liu, T., Wu, Y., Jiang, X.‐S., He, J.‐L., Chen, X.‐M., & Du, X.‐G. (2021). Berberine alleviates palmitic acid‐induced podocyte apoptosis by reducing reactive oxygen species‐mediated endoplasmic reticulum stress. Molecular Medicine Reports, 23(1), 1.
Xiao, H.‐B., Sun, Z.‐L., Zhang, H.‐B., & Zhang, D.‐S. (2012). Berberine inhibits dyslipidemia in C57BL/6 mice with lipopolysaccharide induced inflammation. International Journal of Immunopathology and Pharmacology, 64(4), 889–895.
Xie, D., Xu, Y., Jing, W., Juxiang, Z., Hailun, L., Yu, H., Zheng, D. H., & Lin, Y.‐T. (2017). Berberine nanoparticles protects tubular epithelial cells from renal ischemia‐reperfusion injury. Oncotarget, 8(15), 24154–24162.
Xie, X., Chang, X., Chen, L., Huang, K., Huang, J., Wang, S., Shen, X., Liu, P., & Huang, H. (2013). Berberine ameliorates experimental diabetes‐induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling. Molecular and Cellular Endocrinology, 381(1–2), 56–65.
Xu, D., Wan, C., Wang, T., Tian, P., Li, D., & Wu, Y. (2015). Berberine attenuates cigarette smoke‐induced airway inflammation and mucus hypersecretion in mice. International Journal of Clinical and Experimental Medicine, 8(6), 8641.
Xu, L., Liu, Y., & He, X. J. (2005). Inhibitory effects of berberine on the activation and cell cycle progression of human peripheral lymphocytes. Cellular & Molecular Immunology, 2(4), 295–300.
Yan, F., Wang, L., Shi, Y., Cao, H., Liu, L., Washington, M. K., Chaturvedi, R., Israel, D. A., Cao, H., Wang, B., Peek, R. M., Wilson, K. T., & Polk, D. B. (2012). Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS‐treated mice. American Journal of Physiology. Gastrointestinal and Liver Physiology, 302(5), G504–G514.
Yang, K.‐T., Chao, T.‐H., Wang, I.‐C., Luo, Y.‐P., Ting, P.‐C., Lin, J.‐H., & Chang, J.‐C. (2022). Berberine protects cardiac cells against ferroptosis. Tzu‐Chi Medical Journal, 34(3), 310–317.
Yang, N., Wang, J., Liu, C., Song, Y., Zhang, S., & Zi, J. (2014). Berberine and limonin suppress IgE production by human B cells and peripheral blood mononuclear cells from food‐allergic patients. Annals of Allergy, Asthma & Immunology, 113(5), 556–564. e554.
Ye, Z., Wang, Q., Dai, S., Ji, X., Cao, P., Xu, C., & Bao, G. (2022). The Berberis vulgaris L. extract berberine exerts its anti‐oxidant effects to ameliorate cholesterol overloading–induced cell apoptosis in the primary mice hepatocytes: An in vitro study. In Vitro Cellular & Developmental Biology‐Animal, 58(10), 855–866.
Yi, J., Wu, S., Tan, S., Qin, Y., Wang, X., Jiang, J., Liu, H., & Wu, B. (2021). Berberine alleviates liver fibrosis through inducing ferrous redox to activate ROS‐mediated hepatic stellate cells ferroptosis. Cell Death Discovery, 7(1), 374.
Yin, J., Xing, H., & Ye, J. (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism, 57(5), 712–717.
Yin, X., Fan, X., Zhou, Z., & Li, Q. (2022). Encapsulation of berberine decorated ZnO nano‐colloids into injectable hydrogel using for diabetic wound healing. Frontiers in Chemistry, 10, 964662.
Yu, L., Li, Q., Yu, B., Yang, Y., Jin, Z., Duan, W., Zhao, G., Zhai, M., Liu, L., Yi, D., Chen, M., & Yu, S. (2016). Berberine attenuates myocardial ischemia/reperfusion injury by reducing oxidative stress and inflammation response: Role of silent information regulator 1. Oxidative Medicine and Cellular Longevity, 2016, 1–16.
Yu, T., Yi, Y.‐S., Yang, Y., Oh, J., Jeong, D., & Cho, J. Y. (2012). The pivotal role of TBK1 in inflammatory responses mediated by macrophages. Mediators of Inflammation, 2012(1), 1–8.
Yu, W., Sheng, M., Xu, R., Yu, J., Cui, K., Tong, J., Shi, L., Ren, H., & Du, H. (2013). Berberine protects human renal proximal tubular cells from hypoxia/reoxygenation injury via inhibiting endoplasmic reticulum and mitochondrial stress pathways. Journal of Translational Medicine, 11(1), 1–10.
Zarei, A., Changizi‐Ashtiyani, S., Taheri, S., & Ramezani, M. (2015). A quick overview on some aspects of endocrinological and therapeutic effects of Berberis vulgaris L. Avicenna Journal of Phytomedicine, 5(6), 485.
Zhang, H.‐q., Wang, H.‐d., Lu, D.‐x., Qi, R.‐b., Wang, Y.‐p., Yan, Y.‐x., & Fu, Y.‐m. (2008). Berberine inhibits cytosolic phospholipase A2 and protects against LPS‐induced lung injury and lethality independent of the α2‐adrenergic receptor in mice. Shock, 29(5), 617–622.
Zhang, J., Yang, J.‐Q., He, B.‐C., Zhou, Q.‐X., Yu, H.‐R., Tang, Y., & Liu, B.‐Z. (2009). Berberine and total base from rhizoma coptis chinensis attenuate brain injury in an aluminum‐induced rat model of neurodegenerative disease. Saudi Medical Journal, 30(6), 760–766.
Zhang, M., Liu, J., Yu, C., Tang, S., Jiang, G., Zhang, J., Zhang, H., Xu, J., & Xu, W. (2022). Berberine regulation of cellular oxidative stress, apoptosis and autophagy by modulation of m6A mRNA methylation through targeting the Camk1db/ERK pathway in zebrafish‐hepatocytes. Antioxidants, 11(12), 2370.
Zhang, N., Sheng, M., Wu, M., Zhang, X., Ding, Y., Lin, Y., Yu W., Wang, S., & Du, H. (2019). Berberine protects steatotic donor undergoing liver transplantation via inhibiting endoplasmic reticulum stress‐mediated reticulophagy. Experimental Biology and Medicine, 244(18), 1695–1704.
Zhao, G.‐l., Yu, L.‐m., Gao, W.‐l., Duan, W.‐x., Jiang, B., Liu, X.‐D., Zhang, B., Liu, Z. H., Zhai, M. E., Jin, Z. X., Yu, S. Q., & Wang, Y. (2016). Berberine protects rat heart from ischemia/reperfusion injury via activating JAK2/STAT3 signaling and attenuating endoplasmic reticulum stress. Acta Pharmacologica Sinica, 37(3), 354–367.
Zhao, H., Halicka, H. D., Li, J., & Darzynkiewicz, Z. (2013). Berberine suppresses Gero‐conversion from cell cycle arrest to senescence. Aging (Albany NY), 5(8), 623–636.
Zhou, J., Zhou, S., Tang, J., Zhang, K., Guang, L., Huang, Y., Xu, Y., Ying, Y., Zhang, L., & Li, D. (2009). Protective effect of berberine on beta cells in streptozotocin‐and high‐carbohydrate/high‐fat diet‐induced diabetic rats. European Journal of Pharmacology, 606(1–3), 262–268.
Zhou, J.‐Y., & Zhou, S.‐W. (2011). Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver. Fitoterapia, 82(2), 184–189.

Keywords: Berberis vulgaris; antioxidant; anti‐inflammatory; berberine; immunomodulatory

0 (Antioxidants)
0I8Y3P32UF (Berberine)
0 (Cytokines)
0 (Anti-Inflammatory Agents)

Date Created: 20240215 Date Completed: 20240410 Latest Revision: 20240410

20240410

10.1002/ptr.8077

38358731